Continuous glucose monitors (CGMs) were traditionally designed for diabetics, but their use has expanded to include non-diabetics eager to track their health metrics. However, the psychological impact of wearing these devices can be overwhelming.
One user recounts her journey of using CGMs, starting with the initial excitement of applying the devices to monitor her glucose levels. Despite being non-diabetic, she wanted to explore the technology's potential benefits. However, what began as an experiment turned into an obsession that led to anxiety and mental stress.
Initially, the user found the application of CGMs straightforward and painless, using devices like the Dexcom Stelo and Abbott Lingo. She expected the data to provide insights into her health but quickly became engrossed in the numbers, reviewing her glucose levels multiple times a day. Although her A1C levels were normal, she started feeling anxious about any spikes in her glucose readings.
The rise of CGM technology is noteworthy, with these devices now available over-the-counter and marketed to a broader audience. Non-diabetics, wellness influencers, and biohackers promote the use of CGMs as tools for optimizing health. However, the user’s experience highlights the lack of clarity regarding the benefits for those without diabetes.
After a year of continuous monitoring, the user began to question her health. Despite normal A1C levels, she became fixated on minor fluctuations in her glucose readings, which led her to seek multiple medical opinions. The frequent data review caused her to hyperanalyze her diet and exercise routines, leading to increased stress and anxiety.
The user’s experience reflects a broader concern among healthcare professionals regarding the interpretation of CGM data among non-diabetics. Experts have noted that the devices can provide misleading information, as they measure interstitial glucose rather than blood glucose, complicating the understanding of what constitutes healthy levels.
Throughout her testing, the user faced various challenges, including the cost of CGMs and the potential for device malfunction. Each sensor costs around $100 and lasts about 15 days, making long-term use expensive. But even more troubling was the psychological toll; she found herself avoiding social situations and over-exercising to maintain what she perceived as optimal glucose levels.
As her anxiety grew, the user began to realize that her relationship with food and exercise had become unhealthy. The pressure to achieve perfect glucose readings led to disordered eating behaviors and a fixation on minimizing any potential spikes.
Despite the original intent to gain insights into her health, the user ultimately found herself in a cycle of anxiety and stress. After a final round of testing and consultations with healthcare providers, it became clear that the CGMs had not provided the clarity she sought. While the technology flagged some health issues unrelated to diabetes, the psychological burden overshadowed the potential benefits.
The user's story serves as a cautionary tale about the use of CGMs among non-diabetics. It raises essential questions about the true value of wearable technology and the potential mental health risks involved. While CGMs can offer insights for some, they may also lead to unnecessary anxiety and an unhealthy obsession with data.
In conclusion, while continuous glucose monitors have become popular among non-diabetics aiming to optimize their health, the mental health implications must not be overlooked. The user's experience illustrates the need for careful consideration and guidance in interpreting CGM data, emphasizing that what works for one individual may not be suitable for another.
Source: The Verge News